The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Respiratory Drug Market Research Report 2025
Synopsis
Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.
The global Respiratory Drug market was valued at US$ 43040 million in 2023 and is anticipated to reach US$ 64160 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The classification of Respiratory Drug includes Inhalable & Nasal Spray, Oral and Others, and the proportion of Inhalable & Nasal Spray in 2019 is about 68.82%.
Respiratory Drug widely sold through Hospital and Drugs Store. The most proportion of Respiratory Drug sold through Drugs Store, and the proportion in 2019 is 58.28%.
North America is the largest consumption place, with a consumption market share nearly 35.24% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 28.58%. Moreover, the Asian market is expected to register the highest CAGR during the forecast period.
Market competition is intense. GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, etc. are the leaders of the industry.
This report aims to provide a comprehensive presentation of the global market for Respiratory Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Drug.
Report Scope
The Respiratory Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Mylan
Sumitomo Dainippon
Merck
Beximco
Segment by Type
Inhalable & Nasal Spray
Oral
Others
Segment by Application
Hospital
Drugs Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Respiratory Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Respiratory Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.
The global Respiratory Drug market was valued at US$ 43040 million in 2023 and is anticipated to reach US$ 64160 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The classification of Respiratory Drug includes Inhalable & Nasal Spray, Oral and Others, and the proportion of Inhalable & Nasal Spray in 2019 is about 68.82%.
Respiratory Drug widely sold through Hospital and Drugs Store. The most proportion of Respiratory Drug sold through Drugs Store, and the proportion in 2019 is 58.28%.
North America is the largest consumption place, with a consumption market share nearly 35.24% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 28.58%. Moreover, the Asian market is expected to register the highest CAGR during the forecast period.
Market competition is intense. GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, etc. are the leaders of the industry.
This report aims to provide a comprehensive presentation of the global market for Respiratory Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Drug.
Report Scope
The Respiratory Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Mylan
Sumitomo Dainippon
Merck
Beximco
Segment by Type
Inhalable & Nasal Spray
Oral
Others
Segment by Application
Hospital
Drugs Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Respiratory Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Respiratory Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Respiratory Drug Market Overview
1.1 Product Overview and Scope of Respiratory Drug
1.2 Respiratory Drug Segment by Type
1.2.1 Global Respiratory Drug Market Value Comparison by Type (2024-2030)
1.2.2 Inhalable & Nasal Spray
1.2.3 Oral
1.2.4 Others
1.3 Respiratory Drug Segment by Application
1.3.1 Global Respiratory Drug Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Global Respiratory Drug Market Size Estimates and Forecasts
1.4.1 Global Respiratory Drug Revenue 2019-2030
1.4.2 Global Respiratory Drug Sales 2019-2030
1.4.3 Global Respiratory Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Respiratory Drug Market Competition by Manufacturers
2.1 Global Respiratory Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Respiratory Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Respiratory Drug Average Price by Manufacturers (2019-2024)
2.4 Global Respiratory Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Respiratory Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Respiratory Drug, Product Type & Application
2.7 Respiratory Drug Market Competitive Situation and Trends
2.7.1 Respiratory Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Respiratory Drug Players Market Share by Revenue
2.7.3 Global Respiratory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Respiratory Drug Retrospective Market Scenario by Region
3.1 Global Respiratory Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Respiratory Drug Global Respiratory Drug Sales by Region: 2019-2030
3.2.1 Global Respiratory Drug Sales by Region: 2019-2024
3.2.2 Global Respiratory Drug Sales by Region: 2025-2030
3.3 Global Respiratory Drug Global Respiratory Drug Revenue by Region: 2019-2030
3.3.1 Global Respiratory Drug Revenue by Region: 2019-2024
3.3.2 Global Respiratory Drug Revenue by Region: 2025-2030
3.4 North America Respiratory Drug Market Facts & Figures by Country
3.4.1 North America Respiratory Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Respiratory Drug Sales by Country (2019-2030)
3.4.3 North America Respiratory Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Respiratory Drug Market Facts & Figures by Country
3.5.1 Europe Respiratory Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Respiratory Drug Sales by Country (2019-2030)
3.5.3 Europe Respiratory Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Respiratory Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Respiratory Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Respiratory Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Respiratory Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Respiratory Drug Market Facts & Figures by Country
3.7.1 Latin America Respiratory Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Respiratory Drug Sales by Country (2019-2030)
3.7.3 Latin America Respiratory Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Respiratory Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Respiratory Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Respiratory Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Respiratory Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Respiratory Drug Sales by Type (2019-2030)
4.1.1 Global Respiratory Drug Sales by Type (2019-2024)
4.1.2 Global Respiratory Drug Sales by Type (2025-2030)
4.1.3 Global Respiratory Drug Sales Market Share by Type (2019-2030)
4.2 Global Respiratory Drug Revenue by Type (2019-2030)
4.2.1 Global Respiratory Drug Revenue by Type (2019-2024)
4.2.2 Global Respiratory Drug Revenue by Type (2025-2030)
4.2.3 Global Respiratory Drug Revenue Market Share by Type (2019-2030)
4.3 Global Respiratory Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Respiratory Drug Sales by Application (2019-2030)
5.1.1 Global Respiratory Drug Sales by Application (2019-2024)
5.1.2 Global Respiratory Drug Sales by Application (2025-2030)
5.1.3 Global Respiratory Drug Sales Market Share by Application (2019-2030)
5.2 Global Respiratory Drug Revenue by Application (2019-2030)
5.2.1 Global Respiratory Drug Revenue by Application (2019-2024)
5.2.2 Global Respiratory Drug Revenue by Application (2025-2030)
5.2.3 Global Respiratory Drug Revenue Market Share by Application (2019-2030)
5.3 Global Respiratory Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Respiratory Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Respiratory Drug Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Respiratory Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Respiratory Drug Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Respiratory Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Respiratory Drug Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Vertex
6.4.1 Vertex Corporation Information
6.4.2 Vertex Description and Business Overview
6.4.3 Vertex Respiratory Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Vertex Respiratory Drug Product Portfolio
6.4.5 Vertex Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Respiratory Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Roche Respiratory Drug Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Respiratory Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Respiratory Drug Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Respiratory Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Respiratory Drug Product Portfolio
6.7.5 Teva Recent Developments/Updates
6.8 Chiesi
6.8.1 Chiesi Corporation Information
6.8.2 Chiesi Description and Business Overview
6.8.3 Chiesi Respiratory Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chiesi Respiratory Drug Product Portfolio
6.8.5 Chiesi Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Respiratory Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Respiratory Drug Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Sumitomo Dainippon
6.10.1 Sumitomo Dainippon Corporation Information
6.10.2 Sumitomo Dainippon Description and Business Overview
6.10.3 Sumitomo Dainippon Respiratory Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sumitomo Dainippon Respiratory Drug Product Portfolio
6.10.5 Sumitomo Dainippon Recent Developments/Updates
6.11 Merck
6.11.1 Merck Corporation Information
6.11.2 Merck Respiratory Drug Description and Business Overview
6.11.3 Merck Respiratory Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Merck Respiratory Drug Product Portfolio
6.11.5 Merck Recent Developments/Updates
6.12 Beximco
6.12.1 Beximco Corporation Information
6.12.2 Beximco Respiratory Drug Description and Business Overview
6.12.3 Beximco Respiratory Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Beximco Respiratory Drug Product Portfolio
6.12.5 Beximco Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Respiratory Drug Industry Chain Analysis
7.2 Respiratory Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Respiratory Drug Production Mode & Process
7.4 Respiratory Drug Sales and Marketing
7.4.1 Respiratory Drug Sales Channels
7.4.2 Respiratory Drug Distributors
7.5 Respiratory Drug Customers
8 Respiratory Drug Market Dynamics
8.1 Respiratory Drug Industry Trends
8.2 Respiratory Drug Market Drivers
8.3 Respiratory Drug Market Challenges
8.4 Respiratory Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Respiratory Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Respiratory Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Respiratory Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Respiratory Drug Sales (M Units) of Key Manufacturers (2019-2024)
Table 5. Global Respiratory Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Respiratory Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Respiratory Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Respiratory Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Respiratory Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Respiratory Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Respiratory Drug, Product Type & Application
Table 12. Global Key Manufacturers of Respiratory Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Respiratory Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Respiratory Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Respiratory Drug Sales by Region (2019-2024) & (M Units)
Table 18. Global Respiratory Drug Sales Market Share by Region (2019-2024)
Table 19. Global Respiratory Drug Sales by Region (2025-2030) & (M Units)
Table 20. Global Respiratory Drug Sales Market Share by Region (2025-2030)
Table 21. Global Respiratory Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Respiratory Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Respiratory Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Respiratory Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Respiratory Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Respiratory Drug Sales by Country (2019-2024) & (M Units)
Table 27. North America Respiratory Drug Sales by Country (2025-2030) & (M Units)
Table 28. North America Respiratory Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Respiratory Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Respiratory Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Respiratory Drug Sales by Country (2019-2024) & (M Units)
Table 32. Europe Respiratory Drug Sales by Country (2025-2030) & (M Units)
Table 33. Europe Respiratory Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Respiratory Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Respiratory Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Respiratory Drug Sales by Region (2019-2024) & (M Units)
Table 37. Asia Pacific Respiratory Drug Sales by Region (2025-2030) & (M Units)
Table 38. Asia Pacific Respiratory Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Respiratory Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Respiratory Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Respiratory Drug Sales by Country (2019-2024) & (M Units)
Table 42. Latin America Respiratory Drug Sales by Country (2025-2030) & (M Units)
Table 43. Latin America Respiratory Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Respiratory Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Respiratory Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Respiratory Drug Sales by Country (2019-2024) & (M Units)
Table 47. Middle East & Africa Respiratory Drug Sales by Country (2025-2030) & (M Units)
Table 48. Middle East & Africa Respiratory Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Respiratory Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Respiratory Drug Sales (M Units) by Type (2019-2024)
Table 51. Global Respiratory Drug Sales (M Units) by Type (2025-2030)
Table 52. Global Respiratory Drug Sales Market Share by Type (2019-2024)
Table 53. Global Respiratory Drug Sales Market Share by Type (2025-2030)
Table 54. Global Respiratory Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Respiratory Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Respiratory Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Respiratory Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Respiratory Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Respiratory Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Respiratory Drug Sales (M Units) by Application (2019-2024)
Table 61. Global Respiratory Drug Sales (M Units) by Application (2025-2030)
Table 62. Global Respiratory Drug Sales Market Share by Application (2019-2024)
Table 63. Global Respiratory Drug Sales Market Share by Application (2025-2030)
Table 64. Global Respiratory Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Respiratory Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Respiratory Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Respiratory Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Respiratory Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Respiratory Drug Price (US$/Unit) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. GSK Respiratory Drug Product
Table 74. GSK Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. AstraZeneca Respiratory Drug Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Respiratory Drug Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Vertex Corporation Information
Table 86. Vertex Description and Business Overview
Table 87. Vertex Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Vertex Respiratory Drug Product
Table 89. Vertex Recent Developments/Updates
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Roche Respiratory Drug Product
Table 94. Roche Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Novartis Respiratory Drug Product
Table 99. Novartis Recent Developments/Updates
Table 100. Teva Corporation Information
Table 101. Teva Description and Business Overview
Table 102. Teva Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Teva Respiratory Drug Product
Table 104. Teva Recent Developments/Updates
Table 105. Chiesi Corporation Information
Table 106. Chiesi Description and Business Overview
Table 107. Chiesi Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Chiesi Respiratory Drug Product
Table 109. Chiesi Recent Developments/Updates
Table 110. Mylan Corporation Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Mylan Respiratory Drug Product
Table 114. Mylan Recent Developments/Updates
Table 115. Sumitomo Dainippon Corporation Information
Table 116. Sumitomo Dainippon Description and Business Overview
Table 117. Sumitomo Dainippon Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Sumitomo Dainippon Respiratory Drug Product
Table 119. Sumitomo Dainippon Recent Developments/Updates
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Merck Respiratory Drug Product
Table 124. Merck Recent Developments/Updates
Table 125. Beximco Corporation Information
Table 126. Beximco Description and Business Overview
Table 127. Beximco Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Beximco Respiratory Drug Product
Table 129. Beximco Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Respiratory Drug Distributors List
Table 133. Respiratory Drug Customers List
Table 134. Respiratory Drug Market Trends
Table 135. Respiratory Drug Market Drivers
Table 136. Respiratory Drug Market Challenges
Table 137. Respiratory Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Respiratory Drug
Figure 2. Global Respiratory Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Respiratory Drug Market Share by Type in 2023 & 2030
Figure 4. Inhalable & Nasal Spray Product Picture
Figure 5. Oral Product Picture
Figure 6. Others Product Picture
Figure 7. Global Respiratory Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Respiratory Drug Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Drugs Store
Figure 11. Global Respiratory Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Respiratory Drug Market Size (2019-2030) & (US$ Million)
Figure 13. Global Respiratory Drug Sales (2019-2030) & (M Units)
Figure 14. Global Respiratory Drug Average Price (US$/Unit) & (2019-2030)
Figure 15. Respiratory Drug Report Years Considered
Figure 16. Respiratory Drug Sales Share by Manufacturers in 2023
Figure 17. Global Respiratory Drug Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Respiratory Drug Players: Market Share by Revenue in 2023
Figure 19. Respiratory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Respiratory Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Respiratory Drug Sales Market Share by Country (2019-2030)
Figure 22. North America Respiratory Drug Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Respiratory Drug Sales Market Share by Country (2019-2030)
Figure 26. Europe Respiratory Drug Revenue Market Share by Country (2019-2030)
Figure 27. Germany Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Respiratory Drug Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Respiratory Drug Revenue Market Share by Region (2019-2030)
Figure 34. China Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Respiratory Drug Sales Market Share by Country (2019-2030)
Figure 45. Latin America Respiratory Drug Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Respiratory Drug Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Respiratory Drug Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Respiratory Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Respiratory Drug by Type (2019-2030)
Figure 55. Global Revenue Market Share of Respiratory Drug by Type (2019-2030)
Figure 56. Global Respiratory Drug Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Respiratory Drug by Application (2019-2030)
Figure 58. Global Revenue Market Share of Respiratory Drug by Application (2019-2030)
Figure 59. Global Respiratory Drug Price (US$/Unit) by Application (2019-2030)
Figure 60. Respiratory Drug Value Chain
Figure 61. Respiratory Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
